HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $63,000 | -99.8% | 11,060 | -99.6% | 0.01% | -99.7% |
| Q4 2021 | $26,781,000 | +8.9% | 2,933,351 | +27.5% | 1.56% | +7.3% |
| Q3 2021 | $24,600,000 | +8.0% | 2,301,179 | +56.8% | 1.46% | +11.0% |
| Q2 2021 | $22,778,000 | +302.9% | 1,467,675 | +204.7% | 1.31% | +151.1% |
| Q1 2020 | $5,654,000 | +376.3% | 481,608 | +853.7% | 0.52% | +508.1% |
| Q4 2019 | $1,187,000 | -71.7% | 50,500 | -77.8% | 0.09% | -77.3% |
| Q3 2019 | $4,200,000 | -63.4% | 227,002 | -63.2% | 0.38% | -64.0% |
| Q2 2019 | $11,474,000 | +100.9% | 617,185 | +164.1% | 1.05% | +91.6% |
| Q1 2019 | $5,710,000 | -38.8% | 233,651 | -35.0% | 0.55% | -52.7% |
| Q4 2018 | $9,331,000 | -0.3% | 359,713 | +21.7% | 1.16% | +39.3% |
| Q3 2018 | $9,356,000 | -15.6% | 295,589 | +3.6% | 0.83% | +18.0% |
| Q2 2018 | $11,081,000 | +1231.9% | 285,229 | +846.6% | 0.71% | +394.4% |
| Q1 2018 | $832,000 | – | 30,133 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |